Articles On Biotron (ASX:BIT)

ASX climbs 0.3pc Gold stocks surge, up almost 2pc Retail sales soften, increasing chance of RBA rate cut The Australian share market worked hard for its gains today, seesawing between negative and positive territory before making a convin...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

ASX slides 0.45pc, falling from new 50-day high Gold and resources stocks temper losses Info Tech sector leads market down   After a month of almost uninterrupted gains, the ASX has taken a dip today, shedding 0.45%. The combination of Mo...

ASX gains 0.62pc in trading today RBA cut rates as expected, lopping 25 basis points off the cash rate Rate-sensitive tech and banking stocks make strong gains   With inflation falling firmly in the RBA’s 2-3% target range, another rate c...

Highlights Amplia Therapeutics (ASX:ATX) surges following positive pancreatic cancer trial update LI-S Energy (ASX:LIS) gains with progress on drone battery platform and lithium foil project ASX 200 opens lower amid broad se...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

Highlights: ASX tracking upward, following strong global market trends driven by US-UK trade deal. Forrestania Resources (ASX:FRS) reports positive gold exploration results. Materials sector experiences slight decline, while...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

Highlights: XPON Technologies completes acquisition of Alpha Digital, supporting AI service expansion Anax Metals secures cornerstone backing for Whim Creek joint venture advancement ASX 200 dips in early trade amid declines...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

ASX falls 0.82pc, led down by energy and healthcare stocks Gold rises to all-time high at US$3,215 per ounce Oil falls to levels not seen since April 2020, at height of Covid-19 pandemic Despite pulling back on Tuesday, gold prices have h...

Companies including Cochlear and Telix affirm that tariffs are likely to be a ‘Y2K’ non-event Bell Potter says Trajan shares are worth double their current price Plucky Biotron lives another day after passing the hat   On the evening of D...

ASX tanks 4pc, worst drop since may 2020 Gold, copper, Bitcoin hammered in global rout Abacus Storage King bursts up after receiving buyout proposal    The ASX has taken a big hit on Monday, dropping by 4% as it marked the worst one-day l...

ASX takes a hit on tariff fears Gold hits new records again RBA rates decision in focus   The ASX copped a big blow on Monday, falling by 1.6% and wiping out more than $30 billion in market value as concerns over the looming US tariffs ra...

In the arvo session, the ASX held on to early gains… by a thread Nervy investor/trader eyes now await updates from the US on yet more inflation data and tariff announcements Amid the turmoil, wouldn’t you know it, gold stole the show   Af...

ASX dips after US futures drop and Israel strikes Gold hits new high, coal stock New Hope soars BYD’s five-minute battery charge sparks buzz   The ASX made solid gains before pulling back in the afternoon after US stock futures went into...

ASX dips as traders weigh China’s stimulus against Trump’s tariffs Miners soften blow but insurance stocks still taking hits Trump gives speech to Congress, here’s what he said…   The ASX had a bit of a ride on Wednesday, with a sharp dip...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

Highlights Biotron (ASX:BIT) faces regulatory scrutiny over disclosure practices. Compliance and financial transparency remain key in the biotech sector. The company’s capital strategy adapts to industry challenges. The biotechn...

Biotron (ASX:BIT) has been forced to explain its position to ASX Compliance after being queried by the regulator over why it didn’t classify as ‘price sensitive’ an announcement foreshadowing potential bankruptcy. Listen to the HotCopper...

Australia’s S&P/ASX 200 fell 3.79% in February as global geopolitical and economic uncertainties rattled markets Only four out of 11 S&P/ASX 200 sectors posted gains, primarily driven by defensive sectors Kalgoorlie Gold Mining was...

Highlight Respiri rebrands to Vitasora after raising $4 million to boost growth in the US market. Truscreen secures a strategic partnership in China, facing near-term revenue shifts. Lumos Diagnostics sees revenue increase with new de...

ASX drops on tariff fears; BHP, Rio hit Star Entertainment Group sinks amid financial crisis Life360 shines as Endeavour tanks   It was a rough day for the ASX, dropping 1.16% as fears over new US-China tariffs sent Aussie stocks spiralli...

Telix expects three more US product approvals this year Patrys switches to plan B Biotron’s do-or-die $500,000 capital raising   Analysts reckon Telix Pharmaceuticals (ASX:TLX) has only just started to reach its full potential, with three...

ASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock admits slow rate hikes, while Alibaba rebounds   The ASX had a rough afternoon on Friday, with the market closing near its one-month low. D...

ASX rides the wave ahead of US jobs report Coal stocks tank, but Domino’s soars Traders eye US jobs data for clues on Fed moves   ASX had a bit of a rollercoaster ride on Friday, with the market flipping between gains and losses, as trade...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

ASX 200 lifts on tech rally, miners struggle Barrick Gold threatens Mali shutdown over shipping restrictions Bitcoin bounces back after recent slump   The ASX 200 index crept up 0.34% on Tuesday, thanks to a rally in tech following the Na...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX rises on rally across the board Israel and Hezbollah agree to 60-day ceasefire City Chic tumbles after downbeat update   The Aussie share market enjoyed a solid ride on Wednesday, driven by a broad rally as optimism from Wall Street’s...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX closes flat amid shift from banks to miners CPI slows to 2.7pc, first dip within RBA’s target Fortescue shares soar 6pc on electric truck upgrade   The ASX closed 0.19% lower on Wednesday as the shift from financial stocks to miners...

Biotron (ASX:BIT) has angered shareholders on HotCopper as the results of its latest COVID-treating drug trial come up dusty. “There were no statistically significant differences between drug and placebo groups based on change in SARS-C...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

ASX 200 punches it, record highs back in view  11 of 11 sectors higher, like a well-oiled machine  Great day for small caps, goldies and Augustus Minerals Local markets surged this morning after yet another record-breaking night for Wa...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Biotron (ASX:BIT) has announced that preliminary data analyses from the BIT225-011 Phase 2 clinical trial of its lead antiviral drug BIT225 indicate that the primary objectives have been met.

ASX closes lower, but Energy sector blinks green Uranium mining stocks surged on Peter Dutton’s nuclear plans VanEck to launch Australia’s first Bitcoin ETF tomorrow    Local shares closed Wednesday -0.1% lower as gains in Energy were of...

Biotron jumps after Phase 2 trial success Biotron (ASX:BIT) jumped +15% this morning after announcing promising results from its BIT225-011 Phase 2 clinical trial, indicating that the primary objectives of the study have been achieved. This...

Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6% to 5.5cps on Wednesday following the release of Phase 2 HIV trial results using BIT225-011. Notable also in today’s share price move is a massiv...

Biotron (ASX: BIT) has received further indications that its lead antiviral drug BIT225 is a potential candidate for the treatment of issues related to HIV. The company has informed shareholders that preliminary analyses of data from a Phas...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...